Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Combined With Modified CAG and Haploidentical T Cell Infusion for Elderly MDS/AML
NCT01690507Phase 2Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), sponsored by Chinese PLA General Hospital. Started Nov 2012; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01690507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690507.